Hyperkalemia Drug Lowers Aldosterone
Study demonstrates a novel effect of patiromer treatment in hyperkalemic CKD patients
Study demonstrates a novel effect of patiromer treatment in hyperkalemic CKD patients
Doubling of serum creatinine occured in 1,262 patients studied.
Incidence of UI among men with OSA was 2.3%.
The presence of VUR is linked to an increased risk of UTI and renal scarring.
Major fractures included the proximal humerus, forearm, hip, and clinical vertebral fractures.
The number of urinary incontinence visits has increased from 10.7 million to 13.6 million since 1999.
An analysis of individual participant data from 15 prospective studies suggests a protective effect.
Skeletal-related events occurred in 38% of patients with metastatic castration-resistant prostate cancer.
ADT for prostate cancer may be associated with a reduced risk of inflammatory bowel disease.
Recent studies have cast doubt on the universal superiority of the conventional approach to dialysis.